1/1
Efficacy and safety of EGFR inhibitors and radiotherapy in locally advanced non-small cell lung cancer-Supplementary Material
dataset
posted on 2022-08-10, 16:33 authored by Xue Li, Fang Wang, Huijun Jia, Zhen Lian, Kai Ren, Zhiyong Yuan, Ping Wang, Lujun ZhaoSupplementary table 1: Prisma 2020 checklist
Supplementary Table 2. Summary of efficacy
Supplementary Table 3. The incidence of grade ≥3 AEs in NSCLC treated with EGFR inhibitors combined with (chemo)radiotherapy
